Janssen Scientific Affairs, Llc
Clinical trials sponsored by Janssen Scientific Affairs, Llc, explained in plain language.
A subsidiary of Johnson & Johnson handling scientific affairs for its pharmaceutical division.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Last-Resort cell therapy made available for desperate myeloma patients
Disease control AVAILABLEThis program offers an experimental cell therapy called cilta-cel to people with multiple myeloma who have run out of standard options. It uses a version of the treatment that doesn't meet commercial quality standards but may still help. Participants must be seriously ill and hav…
Sponsor: Janssen Scientific Affairs, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study tracks safety of popular Crohn's and colitis drugs over time
Knowledge-focused Recruiting nowThis study looks at the long-term safety of the drug ustekinumab compared to other biologic treatments in adults with Crohn's disease or ulcerative colitis. Researchers will use health records from the Department of Defense to track rates of cancer, serious infections, and other …
Sponsor: Janssen Scientific Affairs, LLC • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC